{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:37:31Z","timestamp":1772890651592,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004442","name":"National Science Centre, Poland","doi-asserted-by":"publisher","award":["2017\/25\/N\/NZ7\/00544"],"award-info":[{"award-number":["2017\/25\/N\/NZ7\/00544"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004442","name":"National Science Centre, Poland","doi-asserted-by":"publisher","award":["2015\/19\/B\/NZ7\/03543"],"award-info":[{"award-number":["2015\/19\/B\/NZ7\/03543"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ejmech.2020.112437","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T21:41:39Z","timestamp":1592343699000},"page":"112437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Novel anilide and benzylamide derivatives of arylpiperazinylalkanoic acids as 5-HT1A\/5-HT7 receptor antagonists and phosphodiesterase 4\/7 inhibitors with procognitive and antidepressant activity"],"prefix":"10.1016","volume":"201","author":[{"given":"Agnieszka","family":"Jankowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"Sata\u0142a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Ko\u0142aczkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Bucki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"G\u0142uch-Lutwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artur","family":"\u015awierczek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Pociecha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Partyka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Jastrz\u0119bska-Wi\u0119sek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Lubelska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gniewomir","family":"Latacz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicja","family":"Gawalska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej J.","family":"Bojarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Wyska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gra\u017cyna","family":"Ch\u0142o\u0144-Rzepa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112437_bib1","first-page":"248","article-title":"The incidence of mild cognitive impairment: a systematic review and data synthesis","volume":"11","author":"Gillis","year":"2019","journal-title":"Alzheimer\u2019s Dement. Diagnosis, Assess. Dis. Monit."},{"key":"10.1016\/j.ejmech.2020.112437_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017173","article-title":"Prevalence of depression and depressive symptoms among outpatients: a systematic review and meta-analysis","volume":"7","author":"Wang","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejmech.2020.112437_bib3","first-page":"84","article-title":"Novel benzodiazepine-like ligands with various anxiolytic, antidepressant, or pro-cognitive profiles","volume":"5","author":"Prevot","year":"2019","journal-title":"Mol. Neuropsych."},{"key":"10.1016\/j.ejmech.2020.112437_bib4","doi-asserted-by":"crossref","first-page":"7483","DOI":"10.1021\/acs.jmedchem.7b00839","article-title":"Novel 3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole-Based multifunctional ligands with antipsychotic-like, mood-modulating and procognitive activity","volume":"60","author":"Bucki","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112437_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bmc.2015.11.041","article-title":"N-Alkylated arylsulfonamides of (aryloxy)ethyl piperidines: 5-HT7 receptor selectivity versus multireceptor profile","volume":"24","author":"Canale","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112437_bib6","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2147\/NDT.S199746","article-title":"Cognitive impairment in depression: recent advances and novel treatments","volume":"15","author":"Perini","year":"2019","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.ejmech.2020.112437_bib7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.schres.2017.06.029","article-title":"Prevalence, demographic and clinical features of comorbid depressive symptoms in drug na\u00efve patients with schizophrenia presenting with first episode psychosis","volume":"193","author":"Dai","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ejmech.2020.112437_bib8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/psyg.12270","article-title":"The relationship among unawareness of memory impairment, depression, and dementia in older adults with memory impairment in Singapore","volume":"17","author":"Liu","year":"2017","journal-title":"Psychogeriatrics"},{"key":"10.1016\/j.ejmech.2020.112437_bib9","article-title":"Diabetic theory in anti-alzheimer\u2019s drug research and development. Part 1: therapeutic potential of antidiabetic agents","volume":"26","author":"Jankowska","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112437_bib10","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2174\/0929867324666170529122802","article-title":"Multi-target-directed ligands affecting serotonergic neurotransmission for Alzheimer\u2019s disease therapy: advances in chemical and biological research","volume":"25","author":"Jankowska","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112437_bib11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2174\/0929867324666170116125159","article-title":"PDE7-Selective and dual inhibitors: advances in chemical and biological research","volume":"24","author":"Jankowska","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112437_bib12","article-title":"Multifunctional ligands targeting phosphodiesterase as the future strategy for the symptomatic and disease-modifying treatment of Alzheimer\u2019s disease","volume":"26","author":"Jankowska","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112437_bib13","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.neurobiolaging.2013.03.011","article-title":"Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer\u2019s disease","volume":"34","author":"Perez-Gonzalez","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejmech.2020.112437_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fnbeh.2014.00207","article-title":"5-HT7 receptor stimulation and blockade: a therapeutic paradox about memory formation and amnesia","volume":"8","author":"Meneses","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.ejmech.2020.112437_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cellimm.2009.04.005","article-title":"Phosphodiesterase 7A inhibitor ASB16165 suppresses proliferation and cytokine production of NKT cells","volume":"258","author":"Goto","year":"2009","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ejmech.2020.112437_bib16","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1111\/bph.13192","article-title":"PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis","volume":"172","author":"Mestre","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112437_bib17","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.neurobiolaging.2014.10.008","article-title":"Silencing phosphodiesterase 7B gene by lentiviral-shRNA interference attenuates neurodegeneration and motor deficits in hemiparkinsonian mice","volume":"36","author":"Morales-Garcia","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejmech.2020.112437_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejmech.2011.10.040","article-title":"Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model","volume":"47","author":"Redondo","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112437_bib19","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1007\/s00018-013-1340-2","article-title":"Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival","volume":"70","author":"Medina-Rodriguez","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2020.112437_bib20","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1016\/j.bmc.2007.05.017","article-title":"7-Arylpiperazinylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and some of their purine-2,6,8-trione analogs as 5-HT1A, 5-HT2A, and 5-HT7 serotonin receptor ligands","volume":"15","author":"Ch\u0142o\u0144-Rzepa","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112437_bib21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.pharep.2013.12.014","article-title":"7-3-Chlorophenypiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione as a serotonin receptor ligands with potential antidepressant activity","volume":"66","author":"Zygmunt","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2020.112437_bib22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bmc.2014.11.008","article-title":"Antidepressant- and anxiolytic-like activity of 7-phenylpiperazinylalkyl-1,3-dimethyl-purine-2,6-dione derivatives with diversified 5-HT1A receptor functional profile","volume":"23","author":"Partyka","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112437_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1734-1140(13)70960-5","article-title":"New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation","volume":"65","author":"Ch\u0142o\u0144-Rzepa","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2020.112437_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/14756366.2016.1198902","article-title":"Synthesis and biological evaluation of 2-fluoro and 3-trifluoromethyl-phenyl-piperazinylalkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione as potential antidepressant agents","volume":"31","author":"Zag\u00f3rska","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112437_bib25","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/ardp.201600260","article-title":"Aminoalkyl derivatives of 8-Alkoxypurine-2,6-diones: multifunctional 5-HT1A\/5-HT7 receptor ligands and PDE inhibitors with antidepressant activity","volume":"349","author":"Ch\u0142o\u0144-Rzepa","year":"2016","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2020.112437_bib26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/1389450119666180808105056","article-title":"Advances in discovery of PDE10A inhibitors for CNS-related disorders. Part 1: overview of the chemical and biological research","volume":"20","author":"Jankowska","year":"2019","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejmech.2020.112437_bib27","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.2174\/1389450120666190801114210","article-title":"Advances in the discovery of PDE10A inhibitors for CNS-related disorders. Part 2: focus on schizophrenia","volume":"20","author":"\u015awierczek","year":"2019","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejmech.2020.112437_bib28","doi-asserted-by":"crossref","first-page":"6616","DOI":"10.1021\/jm049702f","article-title":"Structure-affinity relationship study on N-(1,2,3,4-Tetrahydronaphthalen-1-yl )-4-Aryl-1-Piperazinealkylamides, a new class of 5-hydroxytryptamine 7 receptor agents","volume":"47","author":"Leopoldo","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"issue":"A1","key":"10.1016\/j.ejmech.2020.112437_bib29","article-title":"Arylsulfonamides for the treatment of CNS diseases","author":"Ko\u0142aczkowski","year":"2012","journal-title":"PCT Int. Appl. WO"},{"key":"10.1016\/j.ejmech.2020.112437_bib30","doi-asserted-by":"crossref","first-page":"7116","DOI":"10.1016\/j.bmc.2007.07.029","article-title":"The influence of modifications in imide fragment structure on 5-HT1A and 5-HT7 receptor affinity and in\u00a0vivo pharmacological properties of some new 1-(m-trifluoromethylphenyl)piperazines","volume":"15","author":"Paluchowska","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112437_bib31","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.bmcl.2015.02.042","article-title":"Synthesis and binding properties of new long-chain 4-substituted piperazine derivatives as 5-HT1A and 5-HT7 receptor ligands","volume":"25","author":"Modica","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112437_bib32","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ejmech.2018.09.021","article-title":"Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4\/7 inhibitors: a new approach for the treatment of pain","volume":"158","author":"Ch\u0142o\u0144-Rzepa","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112437_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172779","article-title":"Novel phosphodiesterases inhibitors from the group of purine-2,6-dione derivatives as potent modulators of airway smooth muscle cell remodelling","volume":"865","author":"W\u00f3jcik-Pszczo\u0142a","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112437_bib34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jmb.2004.01.040","article-title":"Crystal structures of the catalytic domain of phosphodiesterase 4B complexed with AMP, 8-Br-AMP, and rolipram","volume":"337","author":"Xu","year":"2004","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2020.112437_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2020.112437_bib36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/10611869808997889","article-title":"Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors","volume":"6","author":"van de Waterbeemd","year":"1998","journal-title":"J.\u00a0Drug Target."},{"key":"10.1016\/j.ejmech.2020.112437_bib37","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1023\/A:1015040217741","article-title":"Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs","volume":"16","author":"Kelder","year":"1999","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.ejmech.2020.112437_bib38","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A\u00a0BOILED-egg to predict gastrointestinal absorption and brain penetration of small molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2020.112437_bib39","series-title":"OSIRIS Property Explorer Was Used for Prediction of Toxicity","year":"2018"},{"key":"10.1016\/j.ejmech.2020.112437_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2020.112437_bib41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejmech.2018.01.093","article-title":"Computer-aided insights into receptor-ligand interaction for novel 5-arylhydantoin derivatives as serotonin 5-HT7 receptor agents with antidepressant activity","volume":"147","author":"Kucwaj-Brysz","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112437_bib42","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1021\/jm401895u","article-title":"Novel arylsulfonamide derivatives with 5-HT6\/5-HT7 receptor antagonism targeting behavioral and psychological symptoms of dementia","volume":"57","author":"Ko\u0142aczkowski","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112437_bib43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejmech.2018.01.068","article-title":"Novel butanehydrazide derivatives of purine-2,6-dione as dual PDE4\/7 inhibitors with potential anti-inflammatory activity: design, synthesis and biological evaluation","volume":"146","author":"Ch\u0142o\u0144-Rzepa","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112437_bib44","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/cbdd.13106","article-title":"The search for a lead structure among series of potent and selective hydantoin 5-HT7R agents: the drug-likeness in\u00a0vitro study","volume":"90","author":"Latacz","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2020.112437_bib45","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.3390\/molecules24244472","article-title":"Are the hydantoin-1,3,5-triazine 5-HT6R ligands a hope to a find new procognitive and anti-obesity drug? Considerations based on primary in\u00a0vivo assays and ADME-tox profile in\u00a0vitro","volume":"24","author":"Lubelska","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112437_bib46","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s11095-007-9517-8","article-title":"A\u00a0novel design of artificial membrane for improving the PAMPA model","volume":"25","author":"Chen","year":"2008","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.ejmech.2020.112437_bib47","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bmcl.2018.02.003","article-title":"MF-8, a novel promising arylpiperazine-hydantoin based 5-HT 7 receptor antagonist: in\u00a0vitro drug-likeness studies and in\u00a0vivo pharmacological evaluation","volume":"28","author":"Latacz","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112437_bib48","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbr.2011.01.034","article-title":"The effects of selective antagonists of serotonin 5-HT7 and 5-HT1A receptors on MK-801-induced impairment of learning and memory in the passive avoidance and Morris water maze tests in rats: mechanistic implications for the beneficial effects of the novel","volume":"220","author":"Horisawa","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2020.112437_bib49","series-title":"Instant JChem Was Used for Structure Property Prediction and Calculation, Instant JChem 18.4.0","year":"2018"},{"key":"10.1016\/j.ejmech.2020.112437_bib50","series-title":"SwissADME Was Used for Property Prediction","year":"2018"},{"key":"10.1016\/j.ejmech.2020.112437_bib51","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1021\/jm050529c","article-title":"MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist","volume":"48","author":"Cruciani","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112437_bib52","series-title":"Small-Molecule Drug Discovery Suite 2017-4","author":"Schr\u00f6dinger","year":"2017"},{"key":"10.1016\/j.ejmech.2020.112437_bib53","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1016\/j.bmc.2014.07.026","article-title":"Novel N-biphenyl-2-ylmethyl 2-methoxyphenylpiperazinylalkanamides as 5-HT7R antagonists for the treatment of depression","volume":"22","author":"Kim","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112437_bib54","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Yung-Chi","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112437_bib55","first-page":"47","article-title":"A\u00a0new one-trial test for neurobiological studies of memory in rats. 1: behavioral data, Behav","volume":"31","author":"Ennaceur","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2020.112437_bib56","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420304086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420304086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:14:36Z","timestamp":1759328076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420304086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":56,"alternative-id":["S0223523420304086"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112437","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel anilide and benzylamide derivatives of arylpiperazinylalkanoic acids as 5-HT1A\/5-HT7 receptor antagonists and phosphodiesterase 4\/7 inhibitors with procognitive and antidepressant activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112437"}}